Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions - Phase 2 (EspertaMente)
EspertaMente
Esposoma: Biodiversità e Human Functioning Post Lesioni Vascolari Cerebrali Acquisite
1 other identifier
interventional
30
1 country
1
Brief Summary
Grounded in the exposome framework and the bio-psycho-social model of health, this study investigated the effects of artificial light simulating natural sunlight on autonomic regulation, cognitive-motor performance and brain activity in 30 chronic stroke survivors. The aim of the study is to evaluate HRV and EEG recording across four successive conditions. Functional mobility and executive function, were evaluated before and after light exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Sep 2025
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedFirst Submitted
Initial submission to the registry
August 5, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 11, 2026
August 1, 2026
1 month
August 5, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Motor Measure
Timed Up and Go Test: TUG (lower values better performance)
Pre and 10 minutes post light exposure
Secondary Outcomes (9)
Motor Measure
Pre and 10 minutes post light exposure
Motor Measure
Pre and 10 minutes post light exposure
Motor Measure
Pre and 10 minutes post light exposure
Cognitive Measure
Pre and 10 minutes post light exposure
Cognitive Measure
Pre and 10 minutes post light exposure
- +4 more secondary outcomes
Study Arms (1)
Light exposure
EXPERIMENTALPatients will be exposed to one single session of artificial light simulating the natural light
Interventions
Patients were exposed to CoeLux for 15 minutes. During light exposure ECG and EEG recordings were performed according to a structured experimental protocol in four successive conditions alternating periods of darkness and light stimulation. The conditions were: PRE-exposure, Exposure, Immediate Post-Exposure (POST1), and Late Post-Exposure Phase (POST2)) designed to characterize both the acute effects of light exposure and the temporal persistence of the induced modifications. Subjects underwent two points of clinical assessment to investigate cognitive and motor performances before (pre) and after (post) light exposure.
Eligibility Criteria
You may qualify if:
- Subjects with Cerebral Stroke, both ischemic and hemorrhagic, in either pediatric or adult age;
- Age \> 18 years
- Absence of ongoing clinical acute conditions
- Able to provide written informed consent to participate in the study if of legal age, or consent from a legal representative if a minor
- Absence of major psychiatric disorders associated with the disability condition
You may not qualify if:
- Inability to provide informed consent
- Presence of other neurological conditions (e.g. Multiple Sclerosis, Parkinson's Disease…)
- Presence of ongoing clinical acute conditions
- Presence of major psychiatric disorders associated with the disability condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Franco Moltenilead
- IRCCS Eugenio Medeacollaborator
- IRCCS Fondazione Don Carlo Gnocchi ONLUScollaborator
Study Sites (1)
Villa Beretta Rehabilitation Center
Costa Masnaga, Italy, 23845, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Franco Molteni, MD
Villa Beretta Rehabilitation Center- Valduce Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 11, 2026
Study Start
September 1, 2025
Primary Completion
October 15, 2025
Study Completion
October 15, 2025
Last Updated
August 11, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share